Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

4

A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin

Youn Ho Kim , Woo Sik Han , Sun Jae Lee , Sung Nam Oh , Do Won Choi , Kwan Soo Byun , Jong Eun Yeon

Clin Mol Hepatol. 2007;13(3):419-422. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.419

View: 4347 Download: 18

A Case of Metastatic Cutaneous Nodules of Recurrent Hepatocellular Carcinoma

Meyoung Cho, M.D., Chang Soo Choi, M.D., Geom Seog Seo, M.D., Tae Hyeon Kim, M.D., Suck Chei Choi, M.D., Ki Jung Yun, M.D. Haak Cheoul Kim, M.D.

Clin Mol Hepatol. 2007;13(2):234-238. Published online January 1, 1970

View: 2841 Download: 22

Supraumbilical Skin Rash as a Rare Complication of Transvatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma

Yeon Kyeong Kim, Yo Ahn Suh, Yong Whan Song, Jong Gwang Kim, Sook-Hyang Jung, Chul Ju Han, You Cheoul Kim, Chang-Min Kim, Jhin Oh Lee, Byung Hee Lee Kyung Jin Rhim Seung-Sook Lee and Jin-Haeng Chung

Clin Mol Hepatol. 2000;6(3):370-376. Published online January 1, 2000

View: 2528 Download: 17

1 |

Viewed By 5241	MAFLD: How is it different from NAFLD?
Viewed By 4999	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4905	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4675	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4652	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 162	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 136	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 120	MAFLD: How is it different from NAFLD?
Cited By 98	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search